Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Common Stock | Options Exercise | $0 | +50K | +166.67% | $0.00 | 80K | Mar 15, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALZN | Restricted Stock Grant | Options Exercise | $0 | -50K | -100% | $0.00* | 0 | Mar 15, 2022 | Common Stock | 50K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents the vesting of restricted stock. |
F2 | Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc. |
F3 | 2,778 and 47,222 restricted shares previously vested on September 13, 2021 and October 13, 2021, respectively, with the final 50,000 shares of restricted stock vesting on March 15, 2022. |